Summary
- Current Price
- As of today, PRLD price is $4.68, up +3.08% on
- Current Price All-Time High
- PRLD price is currently -95.09% below its historical high of $95.38 set on
- Market Cap
- PRLD current market cap is $373M, up +668.52% over the past 365 days
- Revenue
- PRLD current annual revenue is $12.14M, up +73.43% year-over-year
- Next Earnings
- The next earnings release for PRLD is on
Profile
| Metric | Value |
|---|---|
| Full Name | Prelude Therapeutics Incorporated |
| Ticker | NASDAQ: PRLD |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | preludetx.com |
| Employees | 131 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $4.68 | ||
| Price, 1D Change | +3.08% | |
| $373M | ||
| - | ||
| - | ||
| 2.14 | ||
| $12.14M | ||
| Revenue, 1Y Change | +73.43% | |
| -$1.29 | ||
| EPS, 1Y Change | +22.93% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.29 | ||
| EPS Estimate | -$0.66 | N/A |
| EPS Est. Change | +49.34% | N/A |
| $12.14M | ||
| Revenue Estimate | $37.92M | N/A |
| Revenue Est. Change | +212.36% | N/A |
| $4.68 | ||
| Price Target | $8.00 | - |
| Price Tgt. Change | +70.94% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.77 | -$1.68 | +5.48% | |
| -$1.27 | -$1.29 | -1.80% | |
| -$0.66 | N/A | +49.34% | |
| -$0.86 | N/A | +33.48% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.50M | $7.00M | +366.67% | |
| - | $12.14M | - | |
| $37.92M | N/A | +212.36% | |
| $50.00M | N/A | +311.86% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| +446.09% | ||
| +27.52% | ||
| +668.52% | ||
| +85.31% | ||
| +73.43% | ||
| +100.00% | ||
| +22.93% | ||
| +46.94% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $4.68 | ||
| $3.19 | ||
| $4.35 | ||
| $3.42 | ||
| $4.38 | ||
| $0.04 | ||
| 2.14 | ||
| $0.37 | ||
| 54.96 | ||
| 119.92% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $12.14M | ||
| -$1.29 | ||
| $10.43M | ||
| 85.91% | ||
| -$104.57M | ||
| -861.33% | ||
| -$99.50M | ||
| -819.59% | ||
| -$102.86M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.26 | ||
| 1.99 | ||
| 1.99 | ||
| - | ||
| - | ||
| -5.60 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 22.29 | ||
| 6.19 | ||
| -3.75 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $68.64M | ||
| $103.21M | ||
| $141.32M | ||
| $105.69M | ||
| $72.68M | ||
| $52.99M | ||
| $17.79M | ||
| $2.74M | ||
| $3.98M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $111.64M | ||
| $115.00M | ||
| $1.71M | ||
| $0.00 | ||
| $1.71M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$56.30M | ||
| $53.46M | ||
| $24.82M | ||
| $67.00K | ||
| -$56.37M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| D. Boral Capital | ||
| HC Wainwright & Co. | → | |
| Citizens | → | |
| HC Wainwright & Co. | → | |
| JMP Securities | → | |
| HC Wainwright & Co. | → | |
| JMP Securities | → | |
| HC Wainwright & Co. | → | |
| Citizens Capital Markets | → |
Analyst sentiment
Institutional ownership
No data
Screeners with PRLD
FAQ
- What is the ticker symbol for Prelude Therapeutics Incorporated?
- The ticker symbol for Prelude Therapeutics Incorporated is NASDAQ:PRLD
- Does Prelude Therapeutics Incorporated pay dividends?
- No, Prelude Therapeutics Incorporated does not pay dividends
- What sector is Prelude Therapeutics Incorporated in?
- Prelude Therapeutics Incorporated is in the Healthcare sector
- What industry is Prelude Therapeutics Incorporated in?
- Prelude Therapeutics Incorporated is in the Biotechnology industry
- What country is Prelude Therapeutics Incorporated based in?
- Prelude Therapeutics Incorporated is headquartered in United States
- When did Prelude Therapeutics Incorporated go public?
- Prelude Therapeutics Incorporated initial public offering (IPO) was on September 25, 2020
- Is Prelude Therapeutics Incorporated in the S&P 500?
- No, Prelude Therapeutics Incorporated is not included in the S&P 500 index
- Is Prelude Therapeutics Incorporated in the NASDAQ 100?
- No, Prelude Therapeutics Incorporated is not included in the NASDAQ 100 index
- Is Prelude Therapeutics Incorporated in the Dow Jones?
- No, Prelude Therapeutics Incorporated is not included in the Dow Jones index
- When was Prelude Therapeutics Incorporated last earnings report?
- Prelude Therapeutics Incorporated's most recent earnings report was on May 12, 2026
- When does Prelude Therapeutics Incorporated report earnings?
- The next expected earnings date for Prelude Therapeutics Incorporated is August 13, 2026
Data Sources & References
- PRLD Official Website preludetx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1678660/000119312526099428/0001193125-26-099428-index.htm
- PRLD Profile on Yahoo Finance finance.yahoo.com/quote/PRLD
- PRLD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/prld